Browse 14081 Federal Education Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Education grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| February 20th, 2019 |
Administrative Supplement for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional) |
National Institutes of Health |
| March 6th, 2019 |
OVW FY 2019 Consolidated Grant Program to Address Children and Youth Experiencing Domestic and Sexual Assault and Engage Men and Boys as Allies |
Office on Violence Against Women |
| April 15th, 2019 |
Missile Defense Agency (MDA) Science, Technology, Engineering, and Mathematics (STEM) Boosting Engineering Science and Technology (BEST) Robotics: Kits 2019 |
Missile Defense Agency |
| February 20th, 2019 |
Conference on U.S.-India Defense Ties |
US Mission to India |
| September 7th, 2022 |
Summer Research Education Experience Program (Clinical Trials Not Allowed R25) |
National Institutes of Health |
| March 20th, 2019 |
Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R41/R42 - Clinical Trial Optional) |
National Institutes of Health |
| January 3rd, 2020 |
Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required) |
National Institutes of Health |
| May 22nd, 2019 |
The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratories (U24 Clinical Trials Not Allowed) |
National Institutes of Health |
| March 20th, 2019 |
Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R43/R44 - Clinical Trial Optional) |
National Institutes of Health |
| May 22nd, 2019 |
The Experimental Therapeutics Clinical Trials Network (UM1 Clinical Trials Required) |
National Institutes of Health |
| March 19th, 2019 |
Mobile Technologies Extending Reach of Primary Care for Substance-Use-Disorders (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
| March 19th, 2019 |
Mobile Technologies Extending Reach of Primary Care for Substance-Use-Disorders (R41/R42 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2021 |
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed) |
National Institutes of Health |
| September 7th, 2021 |
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2022 |
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2022 |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2022 |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2021 |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) |
National Institutes of Health |
| January 7th, 2022 |
Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2022 |
Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) |
National Institutes of Health |
|
| January 7th, 2022 |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 27th, 2019 |
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) |
National Institutes of Health |
| September 27th, 2019 |
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) |
National Institutes of Health |
| September 27th, 2019 |
Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
National Institutes of Health |
| September 27th, 2019 |
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 27th, 2019 |
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) |
National Institutes of Health |
| September 27th, 2019 |
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) |
National Institutes of Health |
| September 27th, 2019 |
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) |
National Institutes of Health |
| September 27th, 2019 |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) |
National Institutes of Health |
| September 27th, 2019 |
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) |
National Institutes of Health |
| September 27th, 2019 |
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) |
National Institutes of Health |
| February 21st, 2019 |
U.S.-China Program for Biomedical Collaborative Research (R01 Clinical Trial Optional) |
National Institutes of Health |
| March 4th, 2019 |
Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R43/R44 - Clinical Trial Not Allowed) |
National Institutes of Health |
| March 4th, 2019 |
Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42 - Clinical Trial Not Allowed) |
National Institutes of Health |
| February 12th, 2019 |
Office of Innovation and Improvement (OII): Charter Schools Program (CSP): Grants to State Entities CFDA Number 84.282A |
Department of Education |
| May 17th, 2019 |
NAGPRA Repatriation Grants FY2019 |
National Park Service |
| March 25th, 2019 |
HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) ( R34- Clinical Trial Not Allowed) |
National Institutes of Health |
| December 31st, 2018 |
SCA Interpretation Internship |
National Park Service |
| January 7th, 2022 |
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 8th, 2019 |
NAGPRA Consultation/Documentation Grants FY2019 |
National Park Service |
